Suppr超能文献

硝苯地平与支气管哮喘

Nifedipine in bronchial asthma.

作者信息

Patakas D, Vlachoianni E, Tsara V, Louridas G, Argiropoulou P

出版信息

J Allergy Clin Immunol. 1983 Sep;72(3):269-73. doi: 10.1016/0091-6749(83)90031-3.

Abstract

In 11 patients with bronchial asthma and regular overnight falls in PEFR of greater than 15%, we demonstrated significant bronchodilation restricted only to large airways after the administration of a single dose of 10 mg of nifedipine. A statistically significant increase in PEFR, SGaw, and FEV1 was noticed at 1 and especially 2 hr after nifedipine administration. During 4 days of nifedipine treatment (10 mg t.i.d.), the overnight fall in mean PEFR was statistically significant (p less than 0.02) and less than the mean fall of PEFR during the 4 days of placebo treatment. Thus nifedipine does modify the basal bronchial tone of patients with asthma and diminishes the circadian swing of airway resistance.

摘要

在11例支气管哮喘患者中,其呼气峰流速(PEFR)夜间规律性下降超过15%,我们发现单次给予10毫克硝苯地平后,显著的支气管扩张仅局限于大气道。硝苯地平给药后1小时尤其是2小时,PEFR、比气道传导率(SGaw)和第一秒用力呼气容积(FEV1)有统计学意义的增加。在硝苯地平治疗4天(10毫克,每日三次)期间,平均PEFR的夜间下降有统计学意义(p小于0.02),且低于安慰剂治疗4天期间PEFR的平均下降幅度。因此,硝苯地平确实改变了哮喘患者的基础支气管张力,并减少了气道阻力的昼夜波动。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验